262 related articles for article (PubMed ID: 24498386)
41. McCune Albright syndrome is a genetic predisposition to intraductal papillary and mucinous neoplasms of the pancreas associated pancreatic cancer in relation with GNAS somatic mutation - a case report.
Gaujoux S; Pasmant E; Silve C; Mehsen-Cetre N; Coriat R; Rouquette A; Douset B; Prat F; Leroy K
Medicine (Baltimore); 2019 Dec; 98(50):e18102. PubMed ID: 31852070
[TBL] [Abstract][Full Text] [Related]
42. GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas.
Ritterhouse LL; Vivero M; Mino-Kenudson M; Sholl LM; Iafrate AJ; Nardi V; Dong F
Mod Pathol; 2017 Dec; 30(12):1720-1727. PubMed ID: 28776576
[TBL] [Abstract][Full Text] [Related]
43. Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features.
Omori Y; Ono Y; Tanino M; Karasaki H; Yamaguchi H; Furukawa T; Enomoto K; Ueda J; Sumi A; Katayama J; Muraki M; Taniue K; Takahashi K; Ambo Y; Shinohara T; Nishihara H; Sasajima J; Maguchi H; Mizukami Y; Okumura T; Tanaka S
Gastroenterology; 2019 Feb; 156(3):647-661.e2. PubMed ID: 30342036
[TBL] [Abstract][Full Text] [Related]
44. GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal subtype.
Hata T; Mizuma M; Motoi F; Omori Y; Ishida M; Nakagawa K; Hayashi H; Morikawa T; Kamei T; Furukawa T; Unno M
Sci Rep; 2020 Oct; 10(1):17761. PubMed ID: 33082481
[TBL] [Abstract][Full Text] [Related]
45. How does intestinal-type intraductal papillary mucinous neoplasm emerge? CDX2 plays a critical role in the process of intestinal differentiation and progression.
Omori Y; Ono Y; Kobayashi T; Motoi F; Karasaki H; Mizukami Y; Makino N; Ueno Y; Unno M; Furukawa T
Virchows Arch; 2020 Jul; 477(1):21-31. PubMed ID: 32291497
[TBL] [Abstract][Full Text] [Related]
46. Molecular Diagnostics in the Evaluation of Pancreatic Cysts.
Theisen BK; Wald AI; Singhi AD
Surg Pathol Clin; 2016 Sep; 9(3):441-56. PubMed ID: 27523971
[TBL] [Abstract][Full Text] [Related]
47. Expression of MSX2 predicts malignancy of branch duct intraductal papillary mucinous neoplasm of the pancreas.
Satoh K; Hamada S; Kanno A; Hirota M; Umino J; Ito H; Masamune A; Egawa S; Unno M; Shimosegawa T
J Gastroenterol; 2010 Jul; 45(7):763-70. PubMed ID: 20107842
[TBL] [Abstract][Full Text] [Related]
48. Genomic analysis of pancreatic juice DNA assesses malignant risk of intraductal papillary mucinous neoplasm of pancreas.
Mateos RN; Nakagawa H; Hirono S; Takano S; Fukasawa M; Yanagisawa A; Yasukawa S; Maejima K; Oku-Sasaki A; Nakano K; Dutta M; Tanaka H; Miyano S; Enomoto N; Yamaue H; Nakai K; Fujita M
Cancer Med; 2019 Aug; 8(10):4565-4573. PubMed ID: 31225717
[TBL] [Abstract][Full Text] [Related]
49. A novel
Watanabe K; Nakamura T; Onodera S; Saito A; Shibahara T; Azuma T
Tumour Biol; 2020 Sep; 42(9):1010428320962588. PubMed ID: 32996421
[TBL] [Abstract][Full Text] [Related]
50. Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas.
Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Fukuda E; Shimamoto F; Sueda T; Hiyama E
J Gastrointest Surg; 2008 Jan; 12(1):17-28; discussion 28-9. PubMed ID: 17960465
[TBL] [Abstract][Full Text] [Related]
51. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct.
Sasaki M; Matsubara T; Nitta T; Sato Y; Nakanuma Y
PLoS One; 2013; 8(12):e81706. PubMed ID: 24312577
[TBL] [Abstract][Full Text] [Related]
52. Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.
Basturk O; Chung SM; Hruban RH; Adsay NV; Askan G; Iacobuzio-Donahue C; Balci S; Zee SY; Memis B; Shia J; Klimstra DS
Virchows Arch; 2016 Nov; 469(5):523-532. PubMed ID: 27591765
[TBL] [Abstract][Full Text] [Related]
53. The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.
Basturk O; Tan M; Bhanot U; Allen P; Adsay V; Scott SN; Shah R; Berger MF; Askan G; Dikoglu E; Jobanputra V; Wrzeszczynski KO; Sigel C; Iacobuzio-Donahue C; Klimstra DS
Mod Pathol; 2016 Sep; 29(9):1058-69. PubMed ID: 27282351
[TBL] [Abstract][Full Text] [Related]
54. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.
Tamura K; Ohtsuka T; Ideno N; Aso T; Shindo K; Aishima S; Ohuchida K; Takahata S; Ushijima Y; Ito T; Oda Y; Mizumoto K; Tanaka M
Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056
[TBL] [Abstract][Full Text] [Related]
55. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.
Adsay NV; Merati K; Basturk O; Iacobuzio-Donahue C; Levi E; Cheng JD; Sarkar FH; Hruban RH; Klimstra DS
Am J Surg Pathol; 2004 Jul; 28(7):839-48. PubMed ID: 15223952
[TBL] [Abstract][Full Text] [Related]
56. Pancreatic mucinous noncystic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable.
Lüttges J; Beyser K; Pust S; Paulus A; Rüschoff J; Klöppel G
Mod Pathol; 2003 Jun; 16(6):537-42. PubMed ID: 12808058
[TBL] [Abstract][Full Text] [Related]
57. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma.
Lüttges J; Zamboni G; Longnecker D; Klöppel G
Am J Surg Pathol; 2001 Jul; 25(7):942-8. PubMed ID: 11420467
[TBL] [Abstract][Full Text] [Related]
58. Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Berger AW; Schwerdel D; Costa IG; Hackert T; Strobel O; Lam S; Barth TF; Schröppel B; Meining A; Büchler MW; Zenke M; Hermann PC; Seufferlein T; Kleger A
Gastroenterology; 2016 Aug; 151(2):267-70. PubMed ID: 27343369
[TBL] [Abstract][Full Text] [Related]
59. Expression of claudin-4 (CLDN4) mRNA in intraductal papillary mucinous neoplasms of the pancreas.
Tsutsumi K; Sato N; Cui L; Mizumoto K; Sadakari Y; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Tanaka M
Mod Pathol; 2011 Apr; 24(4):533-41. PubMed ID: 21102412
[TBL] [Abstract][Full Text] [Related]
60. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN
Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
